Inflammatory markers of atherosclerotic plaque stabilization after acute coronary event - Temporal trends;Análise de marcadores de estabilização da placa aterosclerótica após evento coronariano agudo

Arquivos Brasileiros de Cardiologia

Volumn 87, Issue 1, 2006, Pages 28-36

  Mouco, Osana Maria Coelho Costa ^a,b   Nicolau, José Carlos ^a   E Souza, Tatiana Da Rocha ^a   Maia, Lilia Nigro ^a   Ramires, José Antônio Franchini ^a  

^a FACULDADE DE MEDICINA DE SÃO JOSÉ DO RIO PRETO   (Brazil)

^b NONE   (Brazil)

Author keywords

Inflammatory markers; Non ST segment elevation myocardial infarction; Stable angina

Indexed keywords

BLOOD CLOTTING FACTOR 7; C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; INFLAMMATION; MALE; ST SEGMENT ELEVATION;

EID: 33746925161     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2006001400005     Document Type: Article

References (40)

1. Kinlay S, Selwyn AP, Libby P, Ganz P. Inflammation, the endotelium, and the acute coronary syndromes. J Cardiovasc Pharmacol. 1998; 32 (suppl.3): S62-6.
2. Lettino M, Dailey-Sterling F, Badimon L, Chesebro JH, Badimon JJ. Wall passivation for unstable angina. Semin Interv Cardiol. 1996; 1: 60-6.
3. Van der Wal AC, Becker AE. Atherosclerotic plaque rupture-pathologic basis of plaque stability and instability. Cardiovasc Res. 1999; 41: 334-44.
4. Shah PK. Plaque disruption and thrombosis - potential role of inflammation and infection. Cardiol Clin. 1999; 17: 271-81.
5. Ridker PM. Evaluating novel cardiovascular risk factors: can we do better predict heart attacks? Ann Intern Med. 1999; 130: 933-7.
6. Biasucci LM, Vitelli A, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation. 1996; 94: 874-7.
7. Koukkunen H, Penttila K, Kemppainen A, et al. C-reactive protein, fibrinogen, interkeukin-6 and tumour necrosis factor-alpha in the prognostic classification of unstable angina pectoris. Ann Med. 2001; 33: 37-47.
8. Irwin MW, Mak S, Mann DL, et al. Tissue expression and immunolocalization of tumor necrosis factor-α in postinfarction dysfunctional myocardium. Circulation. 1999; 99: 1492-98.
9. Ridker PM. Role of inflammatory biomarkers in prediction of coronary heart disease. Lancet. 2001; 358: 946-8.
10. ECAT Angina Pectoris Study Group. ECAT Angina Pectoris Study: baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Eur Heart J. 1993; 14: 8-17.
11. Bolibar I, Kienast J, Thompson SG, Matthias R, Niessner H, Fechtrup C. Relation of fibrinogen to presence and severity of coronary artery disease is independent of other coexisting heart disease. The ECAT Angina Study Group. Am Heart J. 1993; 125: 1601-5.
12. Meade TW, Mellow S, Brozovic M, et al. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet. 1986; 2: 533-37.
13. Abrignani MG, Novo G, Di Girolamo A, et al. Increased plasma levels of fibrinogen in acute and chronic ischemic coronary syndromes. Cardiologia. 1999; 44: 1047-52.
14. Keshavamurthy CB, Kane GR, Magdum AP, Sahoo PK. Serum fibrinogen and C-reactive protein levels predict major adverse cardiac events in unstable angina. Indian Heart J. 2000; 52: 36-9.
15. Meade TW. Haemostatic function and arterial disease. Br Med Bull. 1994; 50: 755-75.
16. Al-Nozha M, Gader AM, Al-Momen AK, Noah MS, Jawaid M, Arafa M. Haemostatic variables in patients with unstable angina. Int J Cardiol. 1994; 43: 269-77.
17. Olinic D, Brudasca I, Colhon D, Stoia M, Cucuianu M. Increased plasma factor VIII:c activity in patients with unstable angina pectoris. Rom J Intern Med. 1996; 34: 65-71.
18. Tracy RP, Bovill EG, Yanez D, Psaty BM, Fried LP, Heiss G, et al. Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol. 1995; 15: 1269-79.
19. Mulvihill NT, Foley JB, Murphy R, Crean P, Walsh M. Evidence of prolonged inflammation in unstable angina and non-q wave myocardial infarction. J Am Coll Cardiol. 2000; 36: 1210-16.
20. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of Creactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med. 1994; 331: 417-24.
21. Biasucci LM, Liuzzo G, Grillo RL, et al. Elevated levels of C-reactive protein at discharge predicts recurrent instability in patients with unstable angina. Circulation. 1999; 99: 855-60.
22. O'Malley T, Ludlam CA, Riememrsa RA, Fox KAA. Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1): potential risk factor for the acute coronary syndromes. Eur Heart J. 2001; 22: 1226-34.
23. Morrow DA, Rifai N, Antman EM, et al. C-reactive protein is a potent predictor of mortality independently or in combination with troponin T in acute coronary syndromes: a TIMI 11A substudy. J Am Coll Cardiol. 1998; 31: 1460-5.
24. Ferreirós ER, Boissonnet CP, Pizarro R, et al. Independent prognostic value of elevated C-reactive protein in unstable angina. Circulation. 1999; 100: 1958-63.
25. Borras PS, Gomez ME, Romero RA, Campos FC, Molina E, Valentin SV. Inflammation study in unstable angina and myocardial infarction without ST segment elevation. Value of ultra-sensitive C-reactive protein. An Med Interna. 2002; 19: 283-8.
26. Curzen NP, Patel DJ, Kemp M, et al. Can C reactive protein or troponins T and I predict outcome in patients with intractable unstable angina? Heart. 1998; 80: 23-7.
27. Benamer H, Steg PG, Benessiano J, et al. Comparison of the prognostic value of C-reactive protein and troponin in patients with unstable angina pectoris. Am J Cardiol. 1998; 82: 845-50.
28. Choussat R, Montalescot G, Collet J, et al. Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or Cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am J Cardiol. 2000; 8: 379-84.
29. Passoni F, Morelli B, Seveso G, et al. Comparative short-term prognostic value of hemostatic and inflammatory markers in patients with non-ST elevation acute coronary syndromes. Ital Heart J. 2002; 3: 28-33.
30. Cusack MR, Marber MS, Lambiase PD, Bucknall CA, Redwood SR. Systemic inflammation in unstable angina is the result of myocardial necrosis. J Am Coll Cardiol. 2002; 39: 1917-23.
31. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE. Circulating levels of IL-1beta, a prothrombotic cytokine, are elevated in unstable angina versus stable angina. J Thromb Thrombolysis. 2000; 9: 217-22.
32. Basaran Y, Basaran MM, Babacan KF, et al. Serum tumor necrosis factor levels in acute myocardial infarction and unstable angina pectoris. Angiology. 1993; 44: 332-7.
33. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000; 101: 2149-53.
34. Becker RC, Cannon CP, Bovill EG, et al. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Qwave myocardial infarction (TIMI IIIB Trial). Am J Cardiol. 1996; 78: 142-7.
35. Rosenson RS. Myocardial injury: the acute phase response and lipoprotein metabolism. J Am Coll Cardiol. 1993; 22: 933-40.
36. Friesewinkel O, Marbet GA, Ritz R. Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease. Schweiz Med Wochenschr. 1993; 123: 82-4.
37. Montalescot G, Philippe F, Ankri A, et al. Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects enoxaparin. French investigators of the ESSENCE Trial. Circulation. 1998; 98: 294-9.
38. Saitoh M, Matsuo K, Nomoto S, Uchiyama T, Kondoh T, Yanagawa T. Prognostic significance of electrocardiographic change during anginal attack in patients with unstable angina. Intern Med. 2000; 39: 369-74.
39. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999; 340: 448-54.
40. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem. 2000; 46: 461-8.